Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Oded Sagiv Image

      Oded Sagiv, M.D.

      Department of Head and Neck Surgery, Division of Surgery

      Present Title & Affiliation

      Primary Appointment

      Adjunct Associate Professor, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Associate Professor, Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Postgraduate Training

      2022-2023Directors & Senior Executives Program, Tel Aviv University, Tel Aviv
      2021-2022Senior Management Training Prgoram, Sheba Medical Center, Tel Hashomer
      2016-2018Postgraduate Fellow, Ophthalmic Plastic and Reconstructive Surgery and Orbital Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2011-2014Postgraduate Course - Continuing Medical Education in Ophthalmology, The Tel Aviv University, Tel Aviv
      2011-2016Residency in Ophthalmology, Sheba Medical Center, The Goldschleger Eye Institute, affiliated to the Tel Aviv University, Tel Hashomer
      2010-2011Internship (PGY 1), The Tel Aviv Sourasky Medical Center, Affiliated to the Tel Aviv University, Tel-Aviv

      Licenses & Certifications

      2024Texas Medical Board Physician License
      2023Florida Medical Board

      Experience & Service

      Administrative Appointments/Responsibilities

      Site director of rotations in Ophthalmic Plastic and Reconstructive Surgery for Ophthalmology residents of the McGovern Medical School University of Texas Health Science Center at Houston Ophthalmology Residency Program, Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present

      Site director of rotations in Ophthalmic Plastic and Reconstructive Surgery for Ophthalmology residents from the San Antonio Uniformed Services Health Education Consortium (SAUSHEC) Ophthalmology Residency Program, Section of Ophthalmology, Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Program Director for Ophthalmic Plastic and Reconstructive Surgery Fellowship Program (ACGME accredited), Section of Ophthalmology, Department of Head & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - 2025

      Director, Ophthalmology Grand Rounds, Section of Ophthalmology, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Vice-chair of the Department of Ophthalmology, Ophthalmology, Sheba Medical Center, The Goldschleger Eye Institute, Ramat Gan, 2020 - 2023

      Honors & Awards

      2019The Richard Stein Award for Excellence in Research in Ophthalmology, The Tel Aviv University, Israel
      2015Cum Laude, Israeli Medical Association Board Exam in Ophthalmology
      2015Outstanding Lecture- Retina session, Israeli Ophthalmology Society Annual Conference
      2012Doctoral Dissertations (M.D. Thesis) Cum Laude, The Ruth and Bruce Rappaport Faculty of Medicine
      2011Doctor of Medicine - Cum Laude, The Ruth and Bruce Rappaport Faculty of Medicine
      20112011 Best Poster Award (co-author), American Academy of Ophthalmology 2011 Meeting
      2006BA in Medical Sciences - Summa Cum Laude, The Technion - Israel Institute of Technology

      Selected Presentations & Talks

      Regional Presentations

      1. 2026. Multidisciplinary Approach to the Treatment of Lacrimal Sac Carcinomas. Invited. Ophthalmology grand rounds, MCG Eye Clinic. Augusta, Georgia, US.

      National Presentations

      1. 2026. Patient Specific Orbital Implants for treatment of Interosseous hemangioma - two cases. Conference. NASAOS 2026 Annual meeting. Palos Verdes Estates, California, US.
      2. 2026. Intra-Arterial chemotherapy for local control of orbital tumors. Conference. NASAOS 2026 Annual meeting. Palos Verdes Estates, California, US.
      3. 2025. Orbital and Ocular Sequelae of Radiation and Systemic Therapy for Sinonasal Cancers. Invited. American Head and Neck Society 2025 Annual meeting. New Orleans, LA, US.
      4. 2025. Management Strategies for Skull Base Tumor and Surgery Related Orbital Impairment. Invited. North American Skull Base Society (NASBS) 2025 annual meeting. New Orleans, LA, US.
      5. 2025. Management of inadvertent fat transfer to the orbit. Panelist. NASAOS case conference. Virtual, US.
      6. 2024. Management of Orbital Tumors: immunotherapy for orbital metastasis of cutaneous melanoma. Invited. AAO Annual meeting. Chicago, IL, US.
      7. 2024. Immunotherapy without radiation therapy for the treatment of locally advanced orbital cutaneous squamous cell carcinoma with perineural spread. Conference. ASOPRS annual fall meeting 2024. Chicago, IL, US.
      8. 2024. Management of a large optic nerve sheath meningioma. Conference. North American Society of Academic Orbital Surgeons Annual Meeting 2024. Denver, Colorado, US.
      9. 2024. Decompression of the Medial wall of the Orbit in Patient with Thyroid Eye Disease. Invited. NASBS 33rd Annual Meeting. Atlanta, GA, US.
      10. 2024. ENDOSCOPIC ENDONASAL TRANS-SEPTAL APPROACH FOR REMOVAL OF AN ORBITAL APEX CAVERNOUS VENOUS MALFORMATION. Conference. NASBS 33rd Annual Meeting. Atlanta, GA, US.
      11. 2023. Management of Orbital Tumors course. Invited. The American Academy of Ophthalmology. Houston, Texas, US.
      12. 2023. Treatment with Alpha-1 Antagonists for Eyelid Retraction in Patients with Thyroid Eye Disease – A Prospective Pilot Study. Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      13. 2022. Management of lacrimal gland adenoid cystic carcinoma. Invited. American Academy of Ophthalmology. Tel Aviv, IL.
      14. 2022. Different approaches for removing an orbital cavernous venous malformation. Invited. American Academy of Ophthalmology. Tel Aviv, IL.
      15. 2022. Immunotherapy for Locally Advanced Squamous Cell Carcinoma with Perineural Invasion in the Orbit. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Tel Aviv, IL.
      16. 2022. Eyelid-Light Reflex in Patients with Unilateral Horner’s Syndrome. Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery. Tel Aviv, IL.
      17. 2021. Outcomes of Triamcinolone Assisted Anterior Vitrectomy for Cataract Surgeries Complicated with Vitreous Loss. Poster. American Academy of Ophthalmology. Tel Aviv, IL.
      18. 2021. Update on the treatment of malignant eyelid tumors. Invited. Brazilian Congress of Ophthalmology, Virtual. Tel Aviv, IL.
      19. 2020. Change in Eyelid Position between Photopic and Scotopic Conditions Suggests an Eyelid-Light Reflex. Poster. American Academy of Opthalmology. Tel Aviv, IL.
      20. 2020. Change in Eyelid Position between Photopic and Scotopic Conditions Suggests an Eyelid-Light Reflex. Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery. Tel Aviv, IL.
      21. 2019. Orbital Langerhans Cell Histiocytosis. Invited. American Academy of Ophthalmology. Houston, Texas, US.
      22. 2019. Cutaneous Squamous Cell Carcinoma with perineural invasion to the orbit. Invited. American Academy of Ophthalmology. Houston, Texas, US.
      23. 2019. Ocular Preservation with Neoadjuvant Vismodegib in Patients with Locally Advanced Periocular Basal Cell Carcinoma. Invited. MD Anderson Orbital Oncology an Oncologic Oculofacial Plastic Surgery: A Multidisciplinary Approach Conference. Houston, Texas, US.
      24. 2018. Solitary fibrous tumors of the orbit. Invited. American Academy of Ophthalmology. Houston, Texas, US.
      25. 2018. Oribital Ewing Sarcoma. Invited. American Academy of Ophthalmology. Houston, Texas, US.
      26. 2018. Evaluation of periocular ecchymosis. Invited. American Academy of Ophthalmology. Houston, Texas, US.
      27. 2018. Local Control Outcomes After Surgery and Frozen Section Margin Control in 99 Patients with Eyelid Sebaceous Carcinoma. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      28. 2018. Local Control Outcomes After Surgery and Frozen Section Margin Control in 99 Patients with Eyelid Sebaceous Carcinoma. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      29. 2018. Improving Patient Safety by Increasing Participation in Event Reporting Among Trainees at MD Anderson Cancer Center. Poster. Association of American Medical Colleges. Houston, Texas, US.
      30. 2018. Severe Enophthalmos and Corneal Exposure after Maxillectomy. Conference. American Society of Ophthalmic Plastic & Reconstructive. Houston, Texas, US.
      31. 2018. Printed Custom Implant for Orbital Roof Reconstruction After Resection of Cholesterol Granuloma of Orbit. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      32. 2017. Targeting MEK in Patients with Erdheim-Chester Disease of Orbit and Ocular Adnexa. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      33. 2017. Papillary Thyroid Eye Disease as the Harbinger of Thyroid Carcinoma. Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      34. 2017. Pathological Features and Clinical Course in Patients with Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma. Poster. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      35. 2017. Neoadjuvant use of Vismodegib for Locally Advanced Orbital and Periorbital Basal Cell Carcinoma. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      36. 2017. Immune Check Point Inhibitors for Patients with Orbital and Ocular Adnexal Melanoma. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      37. 2017. PD-L1 Expression in Sebaceous Carcinoma of Eyelid: Potential for Immune Checkpoint Blockade as a Treatment Strategy. Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Houston, Texas, US.
      38. 2017. Desmoplastic Melanoma of the Periocular Region. Poster. The Association for Research in Vision and Ophthalmology. Houston, Texas, US.
      39. 2017. PD-L1 Expression in Sebaceous Carcinoma of the Eyelid Implicates the Utility of Immune Checkpoint Blockade. Poster. The United States and Canadian Academy of Pathology. Houston, Texas, US.
      40. 2017. Clinical Outcomes and Histopathologic Features of Orbital Hemangiopericytoma/ Solitary fibrous Tumors. Poster. North American Skull Base Society. Houston, Texas, US.
      41. 2016. Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients. Conference. American Academy of Ophthalmology. Houston, Texas, US.
      42. 2013. Ahmed Glaucoma Valve versus Gold Micro Shunt (GMS) implants - Five years Results of a Prospective Randomized Clinical Trial. Poster. The Association for Research in Vision and Ophthalmology. Houston, Texas, US.
      43. 2009. 5837/A175 Retinal Nerve Fiber Layer Thickness in Patients with Obstructive Sleep Apnea Syndrome (OSAS). Conference. American Society of Ophthalmic Plastic & Reconstructive Surgery. Haifa, IL.

      International Presentations

      1. 2026. Intra-Arterial Chemotherapy for local control of orbital tumors. Conference. International Society of Ocular Oncology (ISOO) Rio 2026 Meeting. Rio de Janeiro, BR.
      2. 2025. Potpourri II session. Panelist. North American Society of Academic Orbital Surgeons (NASAOS) annual meeting 2025. Philadelphia, US.
      3. 2025. Lessons Learned from lacrimal sac carcinoma surgeries. Conference. North American Society of Academic Orbital Surgeons (NASAOS) annual meeting 2025. Philadelphia, US.
      4. 2022. EYESIL Podcast treatment of TED. Invited. Israeli Medical Association. Tel Aviv, IL.
      5. 2022. The tobacco consumption effect on the clinical findings, treatment and prognosis of TED patients. Conference. The Israeli society for vision and eye research (ISVER). Tel Aviv, IL.
      6. 2022. The role of thyroid stimulating immunoglobulin (TSI) in evaluating Thyroid Eye Disease. Poster. The Israeli society for vision and eye research (ISVER). Tel Aviv, IL.
      7. 2021. Change in Eyelid Position between Photopic and Scotopic Conditions Suggests an Eyelid-Light Reflex. Conference. The Israeli society for vision and eye research (ISVER). Tel Aviv, IL.
      8. 2020. Immune checkpoint inhibitors for advanced periocular squamous cell carcinoma. Invited. The 2020 World Ophthalmology Conference, Virtual. Tel Aviv, IL.
      9. 2019. Wide local excision vs Mohs surgery in excision of basal cell carcinoma of the eyelid. Invited. The National Symposium of Controversies in Ophthalmology. Tel Aviv, IL.
      10. 2019. High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. Poster. The Israeli society for vision and eye research (ISVER). Houston, US.
      11. 2019. Update of Eyelid Tumors: Vismodegib for locally advanced BCC and Immune checkpoint inhibitors for eyelid cancers. Invited. The Israel Ophthalmology Society Annual Conference. Houston, US.
      12. 2019. Update on Ocular Adnexal Sebaceous Carcinoma. Invited. The Tel Aviv University Richard Stein Update in Ophthalmology Seminar. Tel Hashomer, IL.
      13. 2018. Is there any change in the thickness of the outer macula after multiple intravitreal injections?. Conference. The Israeli society for vision and eye research (ISVER). Houston, US.
      14. 2017. Subcutaneous Tranexamic Acid in Upper Eyelid Blepharoplasty: A Retrospective Randomized Pilot Study. June 2017. Conference. The Israel Ophthalmoligical Society. Tel Aviv, IL.
      15. 2017. Sonic Hedgehog Inhibitors for Treatment of Locally Advanced Basal Cell Carcinoma of Periocular Region. Conference. International society of ocular oncology (ISOO). Houston, US.
      16. 2016. Comparison of Lateral Orbital Decompression with and without Rim Repositioning in Thyroid Eye Disease. Conference. The Israeli microsurgical meeting. Tel Aviv, IL.
      17. 2016. Advantages of a Multi-Disciplinary Clinic for the Treatment of Patients with Thyroid Eye Disease. Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      18. 2016. Outcome of patients treated with multiple intravitreal Bevacizumab injections for age related macular degeneration. Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      19. 2015. Retinal imaging using spectrally resolved retinal angiography. Conference. The Israeli Society for Vision & Eye Research. Tel Aviv, IL.
      20. 2015. A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Radiotherapy: an In-vivo Animal Model Experiment. Conference. The Israeli Society for Vision & Eye Research. Tel Aviv, IL.
      21. 2015. Dacryocystorhinostomy (DCR) under local anesthesia. Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      22. 2015. Long-term ocular and systemic follow up of Young Patients with retinal vein occlusion. Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      23. 2015. The effect of orbital decompression on the characteristics and outcome of strabismus surgery in thyroid eye disease (TED) patients. Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      24. 2014. Comparison of Lateral Orbital Decompression with and without Rim Repositioning in Thyroid Eye Disease. Conference. The Israeli microsurgical meeting. Tel Aviv, IL.
      25. 2014. Endoscopic Dacryocystorhinostomy with hand-carved bone under Local Anesthesia Without Intravenous Sedation in Patients Without a Previously Failed Dacryocystorhinostomy. Conference. The Israeli microsurgical meeting. Tel Aviv, IL.
      26. 2013. Endoscopic Dacryocystorhinostomy under Local Anesthesia and Hand-Carved Bone. Poster. European Society of Ophthalmic Plastic And Reconstructive Surgery. Tel Aviv, IL.
      27. 2013. Ahmed Glaucoma Valve versus Gold Micro Shunt implants – Five years Results of a Prospective Randomized Clinical Trial. Conference. The Ophthalmic microsurgical Conference. Tel Aviv, IL.
      28. 2013. Atypical case in a patient with childhood-onset SLE. Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      29. 2013. Characterizing The Choroidal Thickness In Different Retinal Diseases Using Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT). Conference. The Israeli Ophthalmological Society. Tel Aviv, IL.
      30. 2012. Ahmed Glaucoma Valve versus Gold Micro Shunt implants – Five years Results of a Prospective Randomized Clinical Trial. Conference. Tel Aviv, IL.

      Formal Peers

      1. 2025. Invited guest speaker: Surgical considerations in treatment of patients with lacrimal sac carcinomas. Houston, Texas, US.
      2. 2025. Update lecture - Surgical considerations in treatment of patients with lacrimal sac carcinomas. Houston, Texas, US.
      3. 2025. Invited Instructor at the American Society of Ophthalmic Trauma Wet Lab, US.
      4. 2024. Immunotherapy for the treatment of orbital metastasis of cutaneous melanoma. Chicago, Ilenois, US.
      5. 2024. Eye-sparing surgery for advanced orbital Optic nerve sheath meningioma with intracranial extension. Houston, Texas, US.
      6. 2024. Non-surgical management of periocular cutaneous melanoma in situ. Houston, Texas, US.
      7. 2024. Invited Instructor at the American Society of Ophthalmic Trauma Wet Lab. Houston, Texas, US.
      8. 2024. Update on new treatments and treatment guidelines for thyroid eye disease. Houston, Texas, US.
      9. 2024. Non-surgical Management of Advanced Periocular Cancers. Invited. Virtual, IL.
      10. 2023. Management of Orbital Tumors: Management of orbital small lymphocytic lymphoma. San Francisco, CA, US.
      11. 2023. Update on Corneal Neurotization – a Novel Treatment for Neurotrophic Keratopathy. Eilat, IL.
      12. 2022. Updates on the treatment of Thyroid Eye Disease. Tel Aviv, IL.
      13. 2022. Management of Orbital Tumors: Management of lacrimal gland adenoid cystic carcinoma, Different approaches for removing an orbital cavernous venous malformation. Chicago, IL, US.
      14. 2021. Update on the treatment of malignant eyelid tumors. Virtual, BR.
      15. 2020. Update on the treatment of malignant eyelid tumors. Virtual.
      16. 2019. Wide local excision vs. Mohs surgery in excision of basal cell carcinoma of the eyelid. Tel Aviv, IL.
      17. 2019. Management of Orbital tumors: Orbital Langerhans Cell Histiocytosis, Cutaneous Squamous Cell Carcinoma with perineural invasion to the orbit. San Francisco, CA, US.
      18. 2019. Update on Eyelid Tumors: Vismodegib for locally advanced BCC and Immune checkpoint inhibitors for eyelid cancers. Tel Aviv, IL.
      19. 2019. Update on Ocular Adnexal Sebaceous Carcinoma. Tel Hashomer, IL.
      20. 2019. Ocular Preservation with Neoadjuvant Vismodegib in Patients with Locally Advanced Periocular Basal Cell Carcinoma. Houston, Texas, US.
      21. 2018. Management of Orbital tumors: Solitary fibrous tumors of the orbit, Orbital Ewing Sarcoma, Evaluation of periocular ecchymosis. Chicago, IL, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Sellers Brandon, Chaudhry Amina, Mitra Devarati, Learned Kim, Sagiv Oded. Radiation Therapy and Nivolumab with Relatlimab-rmbw Achieved a Complete Response in Metastatic Cutaneous Melanoma to the Orbit. Ophthalmic Plast Reconstr Surg Publish Ahead of Print, 2026. e-Pub 2026. PMID: 41528958.
      2. Madgar S, Ben Simon G, Priel A, Sagiv O, Landau Prat D, Cuckierman-Yaffe T, Agmon-Levin N, Shavit R, Smadar L, Zloto O. Thyroid-stimulating immunoglobulins as a reliable predictive blood test for thyroid eye disease. Indian J Ophthalmol 74(1):129-132, 2026. e-Pub 2026. PMID: 41460142.
      3. Lu TJ, Fan J, de Sousa LG, Sagiv O, Hernandez S, Gomez LB, Akhave N, Ferrarotto R, Esmaeli B. PD-1 Inhibitors for Periocular Squamous Cell Carcinoma With Perineural Spread to the Orbit and Skull Base. Ophthalmic Plast Reconstr Surg , 2025. e-Pub 2025. PMID: 40237556.
      4. Katz G, Zloto O, Hostovsky A, Huna-Baron R, Mizrachi IB, Burgansky Z, Skaat A, Vishnevskia-Dai V, Fabian ID, Sagiv O, Priel A, Glicksberg BS, Klang E. Chat GPT vs an experienced ophthalmologist: evaluating chatbot writing performance in ophthalmology. Eye (Lond) 39(10):1948-1953, 2025. e-Pub 2025. PMID: 40169887.
      5. David D, Ben Simon G, Rosner M, Priel A, Sagiv O, Landau Prat D, Zloto O. The change in quality of life after Muller's muscle-conjunctival resection surgery for eyelid ptosis repair. Int Ophthalmol 45(1), 2025. e-Pub 2025. PMID: 40159588.
      6. Priel A, Hadida Barzilai D, Tejman-Yarden S, Vazhgovsky O, Sagiv O, Yakirevitch A, Nakache G, Nagar N, Kapelushnik N, Shivatzki S, Cohen GY, Knoller H, Zloto O. Pre-Operative Planning of a DCR Surgery Using Virtual Reality. Seminars in Ophthalmology 40(1):35-38, 2025. e-Pub 2024. PMID: 39028204.
      7. Arnon R, Rosner M, Priel A, Sagiv O, Landau-Prat D, Rock O, Armarnik S, Shalamaev Y, Arazi M, Zloto O. Frontalis sling surgery - pediatric versus adult population: characteristics and outcomes. BMC Ophthalmology 24(1):534, 2024. e-Pub 2024. PMID: 9696136.
      8. Arnon, R, Rosner, M, Priel, A, Sagiv, O, Prat, D, Rock, O, Armanik, S, Shalamaev, Y, Arazi, M, Zloto, O. Frontalis sling surgery - pediatric versus adult population. BMC Ophthalmology 24(1), 2024. e-Pub 2024. PMID: 39696136.
      9. Aujla J, Tong JY, Curragh D, Caplash Y, Chehade M, Tumuluri K, Au A, Low N, Avisar I, Sagiv O, Barequet I, Ben Simon G. Corneal Neurotization for Neurotrophic Keratopathy: A Multicentre Experience. Ophthalmic Plast Reconstr Surg 40(6):655-660, 2024. e-Pub 2024. PMID: 38624152.
      10. Arnon R, Goldberg H, Ben Simon GJ, Priel A, Zloto O, Landau Prat D, Cukierman-Yaffe T, Agmon-Levin N, Sagiv O. Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease-a prospective pilot study. Eye (Lond) 39(1):175-178, 2024. PMID: 39428445.
      11. Berar OV, Abergel E, Ben Simon G, Rosner M, Priel A, Sagiv O, Landau Prat D, Arazi M, Zloto O. Reoperation for congenital ptosis: characteristics, success rates, and predicting factors. Canadian Journal of Ophthalmology 60(2):e293-e296, 2024. e-Pub 2024. PMID: 39106961.
      12. Gleber-Netto FO, Nagarajan P, Sagiv O, Pickering CR, Gross N, Ning J, Yeshi MM, Mitku Y, Tetzlaff MT, Esmaeli B. Histologic and Genomic Analysis of Conjunctival SCC in African and American Cohorts Reveal UV Light and HPV Signatures and High Tumor Mutation Burden. Invest Ophthalmol Vis Sci 1(65):24, 2024. e-Pub 2024. PMID: 38597722.
      13. Zloto O, Rosset A, Priel A, Landau Prat D, Cukierman-Yaffe T, Shavit R, Argmon-Levin N, Ben Simon G, Sagiv O. Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease. Eye (Lond) 38(4):687-690, 2024. e-Pub 2024. PMID: 37821543.
      14. Arzai, M, Leshno A, Sussman N, Smader L, Huna-Baron R, Sagiv O. Study in Patients With Unilateral Horner Syndrome Supports the Role of Müller's Muscle in the Eyelid-Dark Reflex. IOVS 64(14), 2023. e-Pub 2023. PMID: 38010698.
      15. Landau Prat D, Massarwa S, Zohar A, Priel A, Sagiv O, Zloto O, Ben Simon GJ. Patient-Specific Orbital Implants Vs. Pre-Formed Implants for Internal Orbital Reconstruction. Ophthalmol 38(4):365-370, 2023. e-Pub 2023. PMID: 36639878.
      16. Zloto O, Sagiv O, Priel A, Cukierman-Yaffe T, Tirosh A, Agmon-Levin N, Madgar S, Serlin T, Winter H, Huna-Baron R, Wygnanski-Jaffe T, Ben Simon G. A Multidisciplinary Thyroid Eye Clinic: A One-stop Shop. Isr Med Assoc J 24(10):671-676, 2022. e-Pub 2022. PMID: 36309864.
      17. Leshno A, Sagiv O, Aloni R, Skaat A, Achiron A, Huna-Baron R. Cognitive Performance of Patients With Multiple Sclerosis and Optic Neuritis at Presentation. J Neuroophthalmol 42(1):e8-e13, 2022. e-Pub 2022. PMID: 33870943.
      18. Zloto O, Weissman A, Moroz I, Weidenfeld J, Ben Simon G, Sagiv O, Rosner M, Priel A. Kelly Punch Punctoplasty and Simple Punctal Dilatation Are Equally Effective for Punctal Stenosis: A Prospective Study. Ophthalmic Plast Reconstr Surg 37(6):546-550, 2021. e-Pub 2021. PMID: 33587416.
      19. Zloto O, Sagiv O, Priel A, Cukierman-Yaffe T, Tirosh A, Agmon-Levin N, Madgar S, Serlin T, Ben Simon G. Gender differences in clinical presentation and prognosis of thyroid eye disease. Eur J Ophthalmol 31(5):2717-2723, 2021. e-Pub 2021. PMID: 33158379.
      20. Zloto O, Sagiv O, Priel A, Cukierman-Yaffe T, Tirosh A, Agmon-Levin N, Madgar S, Serlin T, Ben Simon G. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel. Graefes Arch Clin Exp Ophthalmol 259(7):2009-2015, 2021. e-Pub 2021. PMID: 33528651.
      21. Prat D, Gomel N, Zloto O, Anne M, BenSaid A, Bhattacharjee K, Yassur I, Sagiv O, Ben Simon GJ. Low-dose Bleomycin Injections for Orbital Lymphatic and Lymphatic-Venous Malformations: A Multicentric Case Series Study. Ophthalmic Plast Reconstr Surg 37(4):361-365, 2021. e-Pub 2021. PMID: 33156144.
      22. Armarnik S, Kinori M, Abd Elkader A, Blum Meirovitch S, Kapelushnik N, Madgar S, Goldberg H, Sagiv O, Wygnanski-Jaffe T, Priel A. COVID-19's Influence on Ocular Emergency Visits at a Tertiary Referral Center and Its Relationship to Emergency Indications by the American Academy of Ophthalmology. J Ophthalmol, 2021. e-Pub 2021. PMID: 34136280.
      23. Leshno A, Smadar L, Kapelushnik N, Serlin T, Prat D, Priel A, Ben Simon GJ, Sagiv O. New insight into the physiologic function of Muller's muscle. Exp Eye Res 202, 2021. e-Pub 2021. PMID: 33130032.
      24. Zloto O, Matani A, Sagiv O, Prat D, Artsi EB, Leshno A, Priel A, Ben Simon GJ. Changes in Refraction and Visual Acuity after Upper Eyelid Blepharoplasty versus Posterior Approach Ptosis Procedures. Ophthalmic Res 63(6):588-592, 2020. e-Pub 2020. PMID: 32135543.
      25. Sa HS, Rubin ML, Xu S, Ning J, Tetzlaff M, Sagiv O, Kandl TJ, Esmaeli B. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients. Br J Ophthalmol 103(7):980-984, 2019. e-Pub 2019. PMID: 30131380.
      26. Sagiv O, Ding S, Ferrarotto R, Glisson B, Altan M, Johnson F, Elamin Y, Thakar SD, Nagarajan P, Esmaeli B. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma. Ophthalmic Plast Reconstr Surg 35(4):350-353, 2019. e-Pub 2019. PMID: 30365473.
      27. Sagiv O, Nagarajan P, Ferrarotto R, Kandl TJ, Thakar SD, Glisson BS, Altan M, Esmaeli B. Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma. Br J Ophthalmol 103(6):775-780, 2019. e-Pub 2019. PMID: 30021814.
      28. Nagarajan P, El-Hadad C, Gruschkus SK, Hudgens CW, Sagiv O, Gross N, Tetzlaff MT, Esmaeli B. PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma. Invest Ophthalmol Vis Sci 60(6):2388-2398, 2019. e-Pub 2019. PMID: 31141610.
      29. Xu S, Sagiv O, Laura Rubin M, Sa HS, Tetzlaff MT, Nagarajan P, Ning J, Esmaeli B. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma. JAMA Ophthalmol 137(5):537-542, 2019. e-Pub 2019. PMID: 30869769.
      30. Sagiv O, Thakar SD, Manning JT, Kandl TJ, Fayad LE, Fowler N, Hagemeister FB, Fanale MA, Pinnix CC, Samaniego F, Esmaeli B. Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma. Ophthalmic Plast Reconstr Surg 35(3):243-246, 2019. e-Pub 2019. PMID: 30124609.
      31. Sagiv O, Bell D, Guo Y, Su S, Wester ST, Jiang K, Yin VT, Shinder R, Hayek B, Joon Kim H, Tetzlaff MT, Esmaeli B. Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangipericytoma. Ophthalmic Plast Reconstr Surg 35(2):148-154, 2019. e-Pub 2019. PMID: 30371551.
      32. Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, Bell D, Routbort M, Hudgens CW, Ivan D, Kim TB, Chen K, Eterovic AK, Shaw K, Prieto VG, Yemelyanova A, Esmaeli B. Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through non-overlapping molecular-genetic alterations. Clin Cancer Res 25(4):1280-1290, 2019. e-Pub 2019. PMID: 30420449.
      33. Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli B. Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Ophthalmic Plast Reconstr Surg 35(1):50-52, 2019. e-Pub 2019. PMID: 29927883.
      34. Ding S, Sagiv O, Guo Y, Kandl TJ, Thakar SD, Esmaeli B. Change in Eyelid Carcinoma T Category With Use of the 8th Versus 7th Edition of the American Joint Committee on Cancer: Cancer Staging Manual. Ophthalmic Plast Reconstr Surg 35(1):38-41, 2019. e-Pub 2019. PMID: 29877957.
      35. Sagiv O, Rosenfeld E, Kalderon E, Brutman Barazani T, Zloto O, Martinowitz U, Ben Simon GJ, Zilinsky I. Subcutaneous tranexamic acid in upper eyelid blepharoplasty: a prospective randomized pilot study. Can J Ophthalmol 53(6):600-604, 2018. e-Pub 2018. PMID: 30502984.
      36. Sagiv O, Thakar SD, Kandl TJ, Ford J, Sniegowski MC, Hwu WJ, Esmaeli B. Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma. JAMA Ophthalmol 136(11):1236-1241, 2018. e-Pub 2018. PMID: 30352118.
      37. Leshno A, Sachs D, Sagiv O. A Unilateral Triangular Cataract in an Adult. JAMA Ophthalmol 136(10), 2018. e-Pub 2018. PMID: 30326073.
      38. Kandl TJ, Sagiv O, Curry JL, Ning J, Ma J, Hudgens CW, Van Arnam J, Wargo JA, Esmaeli B, Tetzlaff MT. High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. Oncoimmunology 7(9), 2018. e-Pub 2018. PMID: 30228943.
      39. Thuro BA, Sagiv O, Shinder R, Debnam JM, Ozgur O, Ng JD, Rootman D, Thomas SK, Esmaeli B. Clinical Presentation and Anatomical Location of Orbital Plasmacytomas. Ophthalmic Plast Reconstr Surg 34(3):258-261, 2018. e-Pub 2018. PMID: 28582371.
      40. Woo KI, Sagiv O, Han J, Frank SJ, Kim YD, Esmaeli B. Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients. Ophthalmic Plast Reconstr Surg 34(6):570-574, 2018. e-Pub 2018. PMID: 29634603.
      41. Thakar, S, Kandl, TJ, Sagiv, O, Tripathy, D, Tetzlaff, M, Kapur, SK, Myers, JN, Hwu, W, Jaber, BM, Esmaeli, B. Desmoplastic melanoma of the periorbital region. Ophthalmic Plast Reconstr Surg 34(2):e48-e52, 2018. e-Pub 2018. PMID: 29194286.
      42. Sagiv O, Thakar SD, Kandl TJ, Kontoyiannis DP, Debnam JM, Esmaeli B. Clinical Course of Preseptal and Orbital Cellulitis in 50 Immunocompromised Patients with Cancer. Ophthalmology 125(2):318-320, 2018. e-Pub 2018. PMID: 29128228.
      43. Sagiv, O, Thakar, S, Morrell, G, Tetzlaff, M, Esmaeli, B. Rituximab Monotherapy Is Effective in Treating Orbital Necrobiotic Xanthogranuloma. Ophthalmic Plast Reconstr Surg 34(1):e24-e27, 2018. e-Pub 2018. PMID: 28863117.
      44. Andron A, Hostovsky A, Nair AG, Sagiv O, Schiby G, Simon GB. The impact of IgG-4-ROD on the diagnosis of orbital tumors: A retrospective analysis. Orbit 36(6):359-364, 2017. e-Pub 2017. PMID: 28829660.
      45. Sagiv O, Zloto O, Moroz I, Moisseiev J. Different Clinical Courses on Long-Term Follow-Up of Age-Related Macular Degeneration Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Ophthalmologica 238(4):217-225, 2017. e-Pub 2017. PMID: 28926846.
      46. Zloto O, Ben Simon G, Didi Fabian I, Sagiv O, Huna-Baron R, Ben Zion I, Wygnanski-Jaffe T. Association of orbital decompression and the characteristics of subsequent strabismus surgery in thyroid eye disease. Can J Ophthalmol 52(3):264-268, 2017. e-Pub 2017. PMID: 28576206.
      47. Thakar, S, Sagiv, O, Tetzlaff, M, El-Naggar, AK, Debnam, JM, Kandl, TJ, Esmaeli, B. A 60-year-old woman with an asymptomatic left lacrimal gland mass found incidentally. Digit J Ophthalmol 23(4):27-29, 2017. e-Pub 2017. PMID: 29403339.
      48. Sagiv O, Satchi K, Kinori M, Fabian ID, Rosen N, Ben Simon GJ, McNab A. Comparison of lateral orbital decompression with and without rim repositioning in thyroid eye disease. Graefes Arch Clin Exp Ophthalmol 254(4):791-6, 2016. e-Pub 2016. PMID: 26686233.
      49. Skaat A, Sagiv O, Kinori M, Ben Simon GJ, Goldenfeld M, Melamed S. Gold Micro-Shunt Implants Versus Ahmed Glaucoma Valve: Long-term Outcomes of a Prospective Randomized Clinical Trial. J Glaucoma 25(2):155-61, 2016. e-Pub 2016. PMID: 25318574.
      50. Zloto O, Alezra D, Sagiv O, Belkin M, Dai VV, Moroz I, Greenberg G, Ben-Artsi E, Fabian ID. A biological tissue adhesive and dissolvent system for intraocular tumor plaque radiotherapy: an in vivo animal model experiment. Graefes Arch Clin Exp Ophthalmol 253(11):1923-31, 2015. e-Pub 2015. PMID: 26112674.
      51. Sagiv O, Sachs D. Rotation stability of a toric intraocular lens with a second capsular tension ring. J Cataract Refract Surg 41(5):1098-1099, 2015. e-Pub 2015. PMID: 25937341.
      52. Sagiv O, Rosen N, Priel A, Rosner M, Ben Simon GJ. Dacryocystorhinostomy (DCR) under local anesthesia. Harefuah 154(2):110-113, 2015. e-Pub 2015. PMID: 25856864.
      53. Sagiv O, Fishelson-Arev T, Buckman G, Mathalone N, Wolfson J, Segev E, Peled R, Lavi I, Greyer O. Retinal nerve fibre layer thickness measurements by optical coherence tomography in patients with sleep apnoea syndrome. Clin Exp Ophthalmol 42(2):132-8, 2014. e-Pub 2014. PMID: 23777553.
      54. Moisseiev, E, Sagiv, O, Lazar, M. Intense exercise causing central retinal vein occlusion in a young patient. Case Reports in Ophthalmology 5(1):116-120, 2014. e-Pub 2014. PMID: 24847256.
      55. Sagiv, O, Piven, I, Rosner, M. Conjunctival pyogenic granuloma associated with intravitreal bevacizumab injection. Retinal Cases and Brief Reports 7(3):291-293, 2013. e-Pub 2013. PMID: 25391127.

      Review Articles

      1. Esmaeli, B, Sagiv, O. Targeted biological drugs and immune check point inhibitors for locally advanced or metastatic cancers of the conjunctiva, eyelid, and orbit. International Ophthalmology Clinics 59(2):13-26, 2019. e-Pub 2019. PMID: 30908276.

      Professional Educational Materials

      1. Avisar I, Sagiv O, Hamed-Azzam S, Daskin H, Azzam I, Cukierman-Yaffe T, Agmon-Levin N. Guidelines for new treatments for Thyroid Eye Disease. Israel Medical Association, 2022.

      Other Articles

      1. Sagiv, O, Stewart, J, Esmaeli, B Periocular Ecchymoses in Neuroblastoma Metastatic to the Orbit. Ophthalmology 125(7):983, 2018. PMID: 29935671.

      Book Chapters

      1. Tse, DT, Kossler, AL, Feuer, WJ, Benedetto, P, Woo, KI, Sagiv, O, Han, J, Frank, SJ, Kim, YD, Esmaeli, B, Rose, GE, Gore, SK, Plowman, NP. Lacrimal gland carcinoma. In: Foundational Papers in Oculoplastics. Springer, 401-416, 2022.
      2. Sagiv O, Debnam JM, Esmaeli B. Metastatic Orbital Lesions: Melanoma. In: Atlas of Orbital Imaging, 2021.
      3. Sagiv O, Debnam JM, Esmaeli B. Benign (Reactive) Lymphoid Hyperplasia and Lymphoma. In: Atlas of Orbital Imaging. Springer, Cham, 2021.
      4. Sagiv O, Debnam JM, Esmaeli B. Pleomorphic Adenoma of the Lacrimal Gland. In: Atlas of Orbital Imaging. Springer, Cham, 2021.
      5. Sagiv O, Debnam JM, Esmaeli B. Carcinoma Ex-Pleomorphic Adenoma of the Lacrimal Gland. In: Atlas of Orbital Imaging. Springer, Cham, 2021.
      6. Sagiv O, Debnam JM, Esmaeli B. Metastatic Orbital Lesions: Breast Cancer. In: Atlas of Orbital Imaging. Springer, Cham, 2021.
      7. Sagiv O, Debnam JM, Esmaeli B. Lacrimal Gland Prolapse and Dacryops. In: Atlas of Orbital Imaging. Springer, Cham, 2021.
      8. Sagiv O, Debnam JM, Esmaeli B. Orbital Extension of Tumors from the Paranasal Sinuses: Squamous Cell Carcinoma. In: Atlas of Orbital Imaging. Springer, Cham, 2021.
      9. Sagiv O, Debnam JM, Esmaeli B. Lacrimal Gland Carcinoma: Primary. In: Atlas of Orbital Imaging, 2021.
      10. Sagiv O, Debnam JM, Esmaeli B. Differential Diagnosis of Malignant Tumors of the Lacrimal Sac. In: Differential Diagnosis of Malignant Tumors of the Lacrimal Sac. Springer, Cham, 2021.
      11. Sagiv O, Kandl T, Thakar S, Ding S, Esmaeli B. Eyelid Neoplasms: Evaluation and Management. In: Peyman's Principles and Practice of Ophthalmology, 2019.
      12. Thuro B, Thakar S, Sagiv O, Kontoyiannis DP, Esmaeli B. Orbital Cellulitis in Cancer Patients. In: Orbital Cellulitis and Periorbital Infections, 2018.
      13. Sagiv O, Ben Simon GJ. Traumatic Optic Neuropathy. In: Orbital Fractures: Principles, Concepts & Management. Imaging Science Today, 2018.
      14. Sagiv O, Sa HS, Esmaeli B. Special Considerations for Periocular Basal Cell Carcinoma. In: Basal Cell Carcinoma, Advances in Treatment and Research. Springer, Cham.
      15. Chaudhry, A, Al-Zubidi, N, Sagiv, O, Gombos, D, Esmaeli, B. Ophthalmic Emergencies in Cancer Patients. In: Oncologic Emergency Medicine. Springer Nature Switzerland AG 2021.
      16. Esmaeli B, Sagiv O. Chemotherapy and Radiotherapy Effects on the Lacrimal System. In: Lacrimal Disorders: Medical and Surgical Management. Thieme Publishers.
      17. Esmaeli B, Sagiv O. Diagnosis and Management of Malignant Orbital Tumors. In: Finger’s Essential Eye Cancer: Principles and Practice of Ophthalmic Oncology. Kugler.
      18. Esmaeli B, Verdijk RM, Narsing R, Salomao DR, Sagiv O. Merkel Cell Carcinoma. In: Eye and Orbit Tumours, 5th ed. International Agency for Research on Cancer, W.H.O.
      19. Sagiv O, Esmaeli B. Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancies. In: Clinical Ophthalmic Oncology, 3rd Edition (Volume 2: Eyelid and Conjunctival Tumors). Springer Nature.
      20. Sagiv O, Jaber B, Esmaeli B. Targeted and Immune Therapy for Periocular and Orbital Malignancies. In: Orbit and Oculoplastics. Springer, 83-97.
      21. Esmaeli B, Sagiv O. Diagnosis and Management of Benign Orbital Tumors. In: Finger’s Essential Eye Cancer: Principles and Practice of Ophthalmic Oncology. Kugler.
      22. Sagiv O, Ben Simon GJ, Greenberg G, Landau Prat D. Metastatic Orbital Lesions: Lung Cancer, Prostate Cancer, and Renal Cell Carcinoma (RCC). In: Atlas of Orbital Imaging. Springer, Cham.
      23. Sagiv O, Debnam JM, Esmaeli B. Recurrent Pleomorphic Adenoma of the Lacrimal Gland (RLGPA). In: Atlas of Orbital Imaging. Springer Cham.

      Letters to the Editor

      1. Arnon R, Sagiv O. Response to Comment on: "Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease - a prospective pilot study". Eye (Lond) 39: 801, 2025.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 09, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top